Mild Inactivation of RE-1 Silencing Transcription Factor (REST) Reduces Susceptibility to Kainic Acid-Induced Seizures by Carminati, E. et al.
ORIGINAL RESEARCH
published: 10 January 2020
doi: 10.3389/fncel.2019.00580
Edited by:
Mathieu Letellier,
UMR5297 Institut Interdisciplinaire de
Neurosciences (IINS), France
Reviewed by:
Eva Maria Jimenez-Mateos,
Trinity College Dublin, Ireland
Gabriele Losi,
Institute of Neuroscience (CNR), Italy
*Correspondence:
Fabrizia Cesca
fabrizia.cesca@iit.it
Fabio Benfenati
fabio.benfenati@iit.it
†Present address:
Emanuele Carminati,
MolMed SpA, Milan, Italy
Received: 31 August 2019
Accepted: 18 December 2019
Published: 10 January 2020
Citation:
Carminati E, Buffolo F, Rocchi A,
Michetti C, Cesca F and Benfenati F
(2020) Mild Inactivation of RE-1
Silencing Transcription Factor (REST)
Reduces Susceptibility to Kainic
Acid-Induced Seizures.
Front. Cell. Neurosci. 13:580.
doi: 10.3389/fncel.2019.00580
Mild Inactivation of RE-1 Silencing
Transcription Factor (REST) Reduces
Susceptibility to Kainic Acid-Induced
Seizures
Emanuele Carminati1†, Federica Buffolo1, Anna Rocchi1,2, Caterina Michetti1,2,
Fabrizia Cesca1,3* and Fabio Benfenati1,2*
1Center for Synaptic Neuroscience and Technology, Istituto Italiano di Tecnologia, Genova, Italy, 2IRCCS Ospedale Policlinico
San Martino, Genova, Italy, 3Department of Life Sciences, University of Trieste, Trieste, Italy
RE-1 Silencing Transcription factor (REST) controls several steps in neural development
by modulating the expression of a wide range of neural genes. Alterations in REST
expression have been associated with the onset of epilepsy; however, whether such
alterations are deleterious or represent a protective homeostatic response remains
elusive. To study the impact of REST modulation on seizure propensity, we developed a
tool for its negative modulation in vivo. The tool is composed of the paired-amphipathic
helix 1 (PAH1) domain, a competitive inhibitor of REST activation by mSin3, fused to the
light-oxygen-voltage sensing 2 (LOV2) domain of Avena sativa phototropin 1, a molecular
switch to alternatively hide or expose the PAH1 inhibitor. We employed the C450A
and I539E light-independent AsLOV2 variants to mimic the closed (inactive) and open
(active) states of LOV2-PAH1, respectively. Recombinant AAV1/2 viral particles (rAAVs)
allowed LOV2-PAH1 expression in HEK293T cells and primary neurons, and efficiently
transduced hippocampal neurons in vivo. mRNA expression analysis revealed an
increased expression of several neuronal genes in the hippocampi of mice expressing the
open probe. AAV-transduced mice received a single dose of kainic acid (KA), a treatment
known to induce a transient increase of REST levels in the hippocampus. Remarkably,
mice expressing the active variant displayed a reduced number of KA-induced seizures,
which were less severe compared to mice carrying the inactive probe. These data
support the validity of our tool to modulate REST activity in vivo and the potential impact
of REST modulation on epileptogenesis.
Keywords: RE-1 silencing restriction factor (REST), epilepsy, gene transcription, light-oxygen-voltage (LOV)
domain, paired-amphipathic helix 1 (PAH1) domain, kainic acid
INTRODUCTION
The specification of cell identity during central nervous system development is regulated by
positive and negative transcriptional regulators that act simultaneously to shape the cell-specific
transcriptome. The RE1-silencing transcription factor (REST), also known as neuron-restrictive
silencer factor (NRSF), is a transcriptional repressor that binds a specific 21 bp consensus
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sequence named repressor element 1 (RE-1; Chong et al., 1995;
Schoenherr and Anderson, 1995). REST is a member of the
Kruppel-type zinc finger transcription factor family, whose
repressive functions are mediated by two repressor domains: the
N-terminal domain interacts with Sin3 (Grimes et al., 2000),
while the C-terminus recruits CoREST (Andrés et al., 1999; Ballas
et al., 2001). In turn, each co-repressor recruits other associated
proteins and chromatin remodeling factors, including histone
deacetylases (e.g., HDAC1/2), demethylases (e.g., LSD1), and
methyltransferases (e.g., G9a) that mediate the transcriptional
repression of target genes (Ballas et al., 2005). Genome-wide
sequencing analyses identified several thousands putative RE-1
sites (Mortazavi et al., 2006; Johnson et al., 2007; Jothi et al.,
2008), most of which are found in neuron-specific genes (Bruce
et al., 2004; Johnson et al., 2007; Otto et al., 2007). Indeed, REST
represses the expression of various channels, such as sodium
(Chong et al., 1995; Pozzi et al., 2013), calcium (Ariano et al.,
2010; van Loo et al., 2012) and potassium channels (Cheong et al.,
2005). Moreover, it mediates the transcriptional downregulation
of the KCC2 chloride transporter, which is involved in the
GABAergic switch from excitatory to inhibitory transmission
during neuronal maturation (Yeo et al., 2009). Likewise, REST
has been shown to downregulate the expression of Grin2b and
GluR2, which code for the NMDA and AMPA receptor subunits,
respectively (Calderone et al., 2003; Qiang et al., 2005; Rodenas-
Ruano et al., 2012), further supporting its fundamental role in the
modulation of genes involved in synaptic activity and plasticity.
REST is also involved in the control of neurotransmitter release,
whereby it represses several genes involved in neurosecretion,
like SNAREs (D’Alessandro et al., 2009), and in synaptic vesicle
trafficking, like synapsin 1 (Paonessa et al., 2013).
Because of its pleiotropic functions, alterations of REST
expression and/or activity have been described in a wide
spectrum of disorders, including Alzheimer’s (Lu et al., 2014)
and Huntington’s disease (Zuccato et al., 2003, 2007) and
various types of cancer, where it can act as either tumor
suppressor or oncogene, depending on the cellular context
(Negrini et al., 2013). In the brain, increased REST levels
have been observed after epileptic or ischemic insults (Baldelli
and Meldolesi, 2015). In epilepsy, the role of REST is still
debated. On the one hand, it seems to have a protecting role
as it maintains cell homeostasis by downregulating genes like
BDNF (Timmusk et al., 1999; Garriga-Canut et al., 2006);
on the other hand, it appears to participate in the induction
of the disease, mediating epileptogenesis by inhibiting genes
such as HCN1, a hyperpolarization-activated, cyclic nucleotide-
gated channel, involved in synaptic transmission and neuronal
excitability (McClelland et al., 2011, 2014; Patterson et al.,
2017). In vitro and in vivo studies with kainate, an agonist
of glutamatergic receptors, have shown the upregulation of
REST levels in hippocampal and cortical neurons (Palm
et al., 1998; Hu et al., 2011; McClelland et al., 2014), but
whether such increase is protective or deleterious is still not
understood. In a rat model of global ischemia, REST is strongly
upregulated in post-ischemic CA1 neurons, and linked to
neuronal death through the suppression of the AMPA receptor
subunit GluR2 (Calderone et al., 2003), modulation of calcium
permeability and silencing of the µ-opioid receptor 1 (MOR-
1; Formisano et al., 2007). The role of REST in the onset
and development of epileptogenesis was addressed by inducing
the conditional deletion of REST in mice. The progression
of kindling-induced seizures was faster in mice bearing the
Calcium/calmodulin-dependent protein kinase II (CaMKII)-Cre
driven REST deletion, with a concomitant worsening in mossy
fiber sprouting (Hu et al., 2011). In contrast, animals bearing the
neuron-specific enolase (NSE)-Cre driven REST deletion were
characterized by attenuated susceptibility to pentylenetetrazol
(PTZ)-induced seizures (Liu et al., 2012). More recently, the
transient block of REST activity via a decoy strategy enabled the
rescue of the memory impairment induced by febrile seizures
(Patterson et al., 2017). These conflicting data could be explained
by the different seizure models and/or by the different cell
populations where REST was deleted. This suggests that REST
may have different functions in the signaling pathways activated
by the various convulsants, and/or in the various targeted
cell types.
In this work, we have addressed the role of REST in
the modulation of kainic acid (KA)-induced seizures. To do
so, we have exploited a molecular tool composed of the
paired-amphipathic helix 1 (PAH1) domain, a competitive
inhibitor of REST activation by mSin3, fused to the light-
oxygen-voltage sensing 2 (LOV2) domain of Avena sativa
phototropin 1, a molecular switchable to alternatively hide
or expose the PAH1 inhibitor (Paonessa et al., 2016). Our
previous work demonstrated that the LOV-PAH1 probe
efficiently controls the expression of REST target genes in
primary neuronal cultures, thus modulating network excitability
in vitro (Paonessa et al., 2016). Here, we performed intra-
hippocampal injection of AAVs expressing LOV2-PAH1 and
showed that a mild and long-term inhibition of REST activity
reduces the susceptibility of mice to develop KA-induced
seizures in vivo. Overall, our data suggest that REST represents
a potential target for therapeutic approaches addressed to
pathologies characterized by network hyperexcitability, such
as epilepsy.
MATERIALS AND METHODS
Materials
All biochemical reagents and drugs were from Sigma-Aldrich
unless otherwise specified. Tissue culture reagents and media
were from Gibco-Invitrogen (Thermo-Fisher Scientific,
Waltham, MA, USA) or Sigma-Aldrich (Milano, Italy).
Animals
All animals used in this study were mice on the
C57BL/6 background (Charles River, Calco, Italy). All
experiments were carried out in accordance with the guidelines
established by the European Community Council (Directive
2010/63/EU of 22 September 2010) and were approved by
the Italian Ministry of Health (Authorization #73-2014-PR
on Dec 5, 2014). Hippocampal stereotaxic injections (from
Bregma: AP 2.2, LAT 1.5; from brain: Z 1.65) were performed
on C57Bl6/J (12–24 weeks) male mice and neurons transduced
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with either the ‘‘closed state’’ inactive AsLOV2 (C450A)-
PAH1 or the ‘‘open state’’ active AsLOV2 (I539E)-PAH1 variant.
Anesthesia was induced by brief exposure to 4% isoflurane and
maintained by intraperitoneal (IP) injection of the following
anesthetic mixture: ketamine 100 mg/kg, medetomidine
0.65 mg/kg, acepromazine 1.5 mg/kg, atropine 0.05 mg/kg.
Mice were placed in a stereotaxic frame and the head adjusted
to a flat-skull position. A small craniotomy was performed
bilaterally at the injection coordinates indicated above and
rAAV1/2 particles carrying AsLOV2 (C450A)-PAH1 or
AsLOV2 (I539E)-PAH1 were injected in the hippocampus via a
glass pipette (0.65 µl–0.75 µl/site at a flow rate of 0.1 µl/min).
The injection pipette was left in place for at least 5 min at the
end of each injection to allow the complete diffusion of the
virus. After injection, mice were returned to their home cage
and administered with atipamezole (0.65 mg/kg, IP) to speed up
recovery from anesthesia. Mice were allowed to recover for at
least 4 weeks before behavioral experiments.
Cloning and AAV Production
To obtain pAAV-CMV_AsLOV-His_Ires GFP, 20 ng of
pcDNA3.1_AsLOV2_His (Paonessa et al., 2016) were
PCR-amplified using Pfu DNA polymerase (© BiotechRabbit,
Hennigsdorf Germany), using primers #1 and #2 (see below).
PCR conditions were: 95◦C, 5 min; (95◦C, 30 s; 60◦C, 30 s; 72◦C,
1min) for 27 cycles; 72◦C, 5min and 4◦C,∞. PCR products were
digested using Bam HI and Sal I enzymes (NEB, Ipswich, MA,
USA), cloned directly in pAAV-IRES-hrGFP Vector (Agilent,
Santa Clara, CA, USA), digested with the same enzymes and
transformed into TOPTEN cells. Positive colonies were verified
by DNA sequencing. To obtain pAAV-CMV_AsLOV-PAH-
His_Ires GFP, we proceeded as described above, but starting
from pcDNA3.1_AsLOV2_PAH1b_His (Paonessa et al., 2016).
Primer #1 (Fw) 5′CCACCATGGGCGAATTCTTG3′
Primer #2 (Rv) 5′ATCCGTCGACTCACTTCAATGGTGATG
GTGATGATGAC3′
AAV1/2 expressing pAAV-CMV_AsLOV-His_Ires GFP and
pAAV-CMV_AsLOV-PAH-His_Ires GFP were generated as
previously described (McClure et al., 2011). Briefly, human
embryonic kidney (HEK)293T cells were co-transfected with the
required AAV vector together with the plasmids pRV1, pH21 and
pHelper using a Ca2+ phosphatemethod. Forty-eight hours post-
transfection, cells were harvested and lysed, and viruses purified
over heparin columns (GE HealthCare Life Science, Milano,
Italy). Viral vectors were titrated at concentrations ranging from
1 × 1011 to 1 × 1012 transducing units (TU)/ml and used at
a multiplicity of infection (MOI) of 10,000. The efficiency of
infection, estimated by counting neurons expressing GFP protein
with respect to the total number of cells stained with DAPI,
ranged between 70% and 90%.
Cell Culture and Transfection/Infection
Immortalized Cells
HEK293T cells were cultured in DMEM (#11965-092)
supplemented with 10% (vol/vol) fetal bovine serum (FBS),
glutamine (2 mM), and antibiotics, in a humidified 5%
CO2 atmosphere at 37◦C. For immunostaining experiments,
180,000 cells were seeded on 24-mm coverslips and the day
after were transiently transfected with Lipofectamine 2000 (Life
Technologies) following standard transfection procedures.
Primary Neurons
Primary cortical neurons were obtained from E18 embryos
derived from crosses of C57BL/6 wild type mice. Mice were
mated overnight and separated the following morning. The
development of the embryos was timed from the detection of
a vaginal plug, which was considered day 0.5. Cortices were
dissected in ice-cold phosphate-buffered saline (PBS), incubated
with trypsin (0.125%) for 15 min at 37◦C, and mechanically
dissociated. Neurons were plated in Neurobasal medium
containing 10% horse serum, 2 mM glutamine and antibiotics
(plating medium). After 3 h, the medium was removed and
replaced with Neurobasal containing 2% B27 supplement, 2 mM
glutamine and antibiotics (maintenance medium). Neurons were
infected at 5 DIV. Experiments were performed 12 days after
infection (17 DIV).
Western Blotting
Both tissues and cells were lysed in RIPA buffer (10 mM
Tris-HCl pH 7.4, 140 mM NaCl, 1 mM EDTA, 0.5 mM EGTA,
1% Triton X-100, 0.1% SDS, 0.1% sodium deoxycholate)
supplemented with proteases and phosphatase inhibitors
[complete EDTA-free protease inhibitors, Roche Diagnostics
(Monza, Italy); serine/threonine phosphatase inhibitor and
tyrosine phosphatase inhibitor, Sigma] and equal amounts of
proteins were loaded, as determined by BCA Protein Assay
kit (Thermo Scientific). SDS-PAGE and western blotting were
performed following standard procedures. After incubation
with primary antibodies, membranes were incubated with
HRP-conjugated secondary antibodies and ECL Prime Western
Blotting System (GE Healthcare) and subsequently imaged
using a ChemiDoc imaging system (Biorad, Hercules, CA,
USA). Densitometric analysis was performed with Image Lab
software (Biorad). The following primary antibodies were
used for western blotting: rabbit polyclonal anti-REST 1:1,000
(#07-579, Merck-Millipore, Darmstadt, Germany), rabbit
polyclonal anti-calnexin 1:50,000 (#ADI-SPA-860, Enzo Life
Sciences, Farmingdale, New York, USA), rabbit polyclonal
anti-GFP 1:1,000 (#a11122, Invitrogen); mouse monoclonal
anti-His 1:1,000 (#sc-57598, Santa Cruz Biotechnologies,
Dallas, TX, USA).
Immunocytochemistry,
Immunohistochemistry and Confocal
Imaging
Cells were fixed in PBS/4% paraformaldehyde (PFA) for 15 min
and washed in PBS. Cells were permeabilized with 0.2% Triton-X
100 in PBS for 10 min at room temperature (RT) then
incubated with primary antibodies diluted in PBS 1% BSA
overnight at 4◦C or 2 h at RT. After washes in PBS, cells
were incubated with fluorescent secondary antibodies diluted
in PBS 1% BSA. After washes, coverslips were mounted with
Mowiol. For brain slices, mouse brains were dissected and
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fixed overnight in PBS/4% PFA. They were then cryoprotected
in 20% and then 30% sucrose, embedded in OCT, frozen in
isopentane (−55◦C), and stored at −80◦C. Coronal sections
(18 µm) were cut with a cryostat and stored at −20◦C before
immunostaining. Sections were rehydrated in PBS for 5 min
and then incubated in 1% Triton X-100 in PBS for 5 min.
Slices were blocked for 1 h in PBS containing 5% BSA and
incubated with primary antibodies for 24 h at 4◦C. After washes
in PBS, the slices were incubated with secondary antibodies for
2 h at RT, thoroughly washed and mounted on glass slides
with Mowiol. All antibodies were diluted in PBS/5% BSA.
Confocal images were obtained using a Leica SP8 confocal
scan with a 40×/1.3 oil immersion objective and analyzed
with the Leica LAS AF software (Leica Microsystem GmbH,
Wetzlar, Germany).
The following primary antibodies were used for
immunocytochemistry on fixed cells: rabbit polyclonal anti-GFP
1:500 (#a11122, Invitrogen); mouse monoclonal anti-His 1:200
(#ab18184, Abcam, Cambridge, UK). The following primary
antibodies were used for immunohistochemistry on brain
slices: rabbit polyclonal anti-REST 1:100 (#07-579, Merck-
Millipore), mouse monoclonal anti-glial fibrillary acidic protein
1:1,000 (GFAP, #G3893, Sigma-Aldrich), mouse monoclonal
anti-Neuronal Nuclei (NeuN, MAB377 Merck-Millipore).
Fluorescently conjugated secondary antibodies were from
Molecular Probes (Thermo-Fisher Scientific; Alexa Fluor 488,
#A11029; Alexa Fluor 546, #A11030; Alexa Fluor 647, #A21450).
Hoechst (#B2261, Sigma-Aldrich) was used to stain nuclei.
RNA Extraction, Nanostring Analysis, and
Real-Time PCR
Total RNA was extracted with the RNeasyr Microarray Tissue
Kit (Qiagen, Hilden, Germany) from the hippocampi of wild type
mice expressing either the ‘‘closed’’ or the ‘‘open’’ probes. The
corresponding cDNAs were prepared by reverse transcription of
1 µg of RNA using the SuperScript IV Reverse Transcriptase
(ThermoFisher) with an oligo-dT primer according to the
manufacturer’s instructions. The resulting cDNAs were used
as a template for RT-qPCR using a C1000 TouchTM Thermal
Cycler (BioRad) on a CFX96TMReal-Time System following
the manufacturer’s protocol. Relative gene expression was
determined using the ∆∆CT method. To normalize expression
data, primers for 10 commonly used housekeeping genes were
used, and the normalization factor was determined using the
geNorm software, as described (Vandesompele et al., 2002). This
led to the selection of the following internal control genes in our
assays: glyceraldehyde 3-phosphate dehydrogenase (Gapdh) and
actin. Sequences of the primers used are listed in Supplementary
Table S1.
For the Nanostring analysis of neuronal genes, fluorescently
labeled probes were designed and synthesized by Nanostring
Technologies (Supplementary Table S2). One hundred
nanograms total RNA per sample, prepared as described
above, was processed by Synlab Italia S.r.l. (Monza, IT) following
standard procedures. Data were analyzed by using the nSolver
Analysis Software Version 2.5.
KA Injection and Seizure Scoring
To determine the dose-response of KA (Figure 2C), C57BL6/J
mice were repeatedly injected with unitary doses of KA (5 mg/kg
IP, in 0.9% saline) every 10 min and continuously monitored
after each injection. Seizure scoring was conducted as described
below. To induce seizures in transduced animals, mice received
a single IP injection of vehicle or KA (25 mg/kg). In the
KA-treated groups, behavioral seizures were evaluated off-line
from video recordings taken during 1 h following the injection.
Seizure scoring was conducted based on a modified version
of Racine scale (Racine, 1972; McLeod et al., 2013) and
the following parameters were considered: 0 = immobility,
1 = erratic twitches, 2 = straight tail, 3 = forepaws shaking,
4 = straight tail together with forepaw shaking (one time),
5 = continuously (>2) show an extended tail shake with
forepaw shaking, 6 = display full tonic-clonic seizures. In
case of severe attacks (severity score 6) the experiment and
video recordings were stopped immediately after the attacks.
For immunohistochemical and western blotting evaluation of
REST induction, mice were sacrificed at the indicated times
after KA administration. Dissection for mRNA extraction
and Nanostring/qRT-PCR experiments was performed under a
stereomicroscope equipped with a fluorescence lamp to isolate
the GFP-expressing hippocampal tissue.
Statistics
Data are presented as means ± SEM throughout. D’Agostino’s
and Pearson’s test were used to check the normality of the
experimental data. The two-tailed unpaired Student’s t-test was
used to compare two normally distributed sample groups, while
one-way ANOVA followed by Tukey’s multiple comparison
test was used to compare more than two normally distributed
sample groups. For datasets of non-normal distribution, the
Mann–Whitney U-test was used. The occurrence of a given
behavioral trait in the mouse population was evaluated using
the Chi-squared test. Alpha levels for all tests were 0.05% (95%
confidence intervals). Statistical analysis was performed using
GraphPad Prism 6 software (GraphPad Software Inc., San Diego,
CA, USA).
RESULTS
Cloning and Expression of AsLOV2-Based
REST-Inhibiting and Control Probes
To study the impact of REST modulation on epileptogenesis,
we developed a tool for its specific inhibition in vivo. The tool
is composed of the PAH1 domain, fused to the photosensitive
light-oxygen-voltage sensing (LOV) 2 domain of Avena sativa
phototropin 1 (AsLOV2; Paonessa et al., 2016). PAH1 is the
REST-interacting region of the mSin3 protein, which is part
of the repressive REST complex (Grimes et al., 2000). We
previously demonstrated that PAH1 is a competitive REST
inhibitor (Paonessa et al., 2016). For in vivo transduction, we
cloned the sequence coding for the His-tagged fusion protein
into an AAV1/2 vector. In the construct, the expression of the
probe is driven by the CMV promoter, while the expression
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FIGURE 1 | (A) Scheme of the AAV construct used throughout the study. ITR, inverted terminal repeats; pCMV, cytomegalovirus promoter; AsLOV2-PAH1, Avena
sativa light-oxygen-voltage (LOV) domain 2 fused to the paired-amphipathic helix (PAH) domain 1 of the Sin3A protein; IRES, internal ribosomal entry site; GFP, green
fluorescent protein; hGH pA, human growth hormone polyA. The positions of His tag and stop codon are indicated. (B) HEK293T cells were transfected with the
AsLOV2-PAH1 construct, lysed and processed for western blotting using anti-His and anti-GFP antibodies, as indicated. Cortical neurons were infected at 7 DIV with
recombinant AAV1/2 particles expressing AsLOV2-PAH1, lysed at 17 DIV and processed as described above. Duplicate lanes refer to two different
cultures/experiments. (C) Cortical neurons were infected at 7 DIV with recombinant AAV1/2 particles expressing AsLOV2-PAH1, fixed at 17 DIV and processed for
immunocytochemistry using anti-His (red channel), anti-GFP (green channel) and Hoechst to visualize nuclei (blue channel). Scale bar, 20 µm.
of a GFP cassette is controlled by the IRES sequence, allowing
the fluorescence detection of transduced neurons (Figure 1A).
We verified the efficiency of transduction and the expression of
the probe by immunoblotting of transfected HEK293T cells and
transduced primary neurons (Figure 1B). The probe localized in
the cytoplasm of neurons, as detected by immunocytochemistry
and confocal imaging (Figure 1C).
Kainic Acid Injection Induces a Transient
Increase in REST Expression
Increased REST levels have been reported in several experimental
models of epilepsy (Spencer et al., 2006; Hu et al., 2011). Here,
we examined REST protein expression in the hippocampus upon
pharmacological induction of epileptogenesis via IP injection
of (KA, 25 mg/Kg), or saline as a control. We assessed
REST protein levels by immunohistochemistry on coronal brain
slices followed by confocal microscopy analysis. Slices were
co-stained with anti-REST antibodies, anti-NeuN antibodies
to detect neurons, anti-GFAP antibodies to detect astrogliosis
associated with KA-induced epileptogenesis, and Hoechst to
visualize nuclei. We detected increased REST immunoreactivity
in slices from KA-treated animals compared to saline-treated
control samples (Figure 2A, compare right and left panel). The
specificity of the anti-REST antibodies was confirmed by the
absence of signal in slices incubated with secondary antibodies
only, omitting primary antibodies (not shown). The increase in
REST expression peaked 24 h after KA injection, as revealed by
immunoblotting of lysates obtained from dissected hippocampi
(Figure 2B). At the dose used, KA induced seizures in all animals,
in the majority of cases of severity 5/6 (Figure 2C).
Chronic REST Inhibition Leads to
Increased Neuronal Gene Expression
To assess the functionality of our construct in vivo, AAV1/2-
AsLOV2 recombinant viral particles (1 µl/hemisphere) were
injected in the hippocampus of adult C57Bl6/J mice (Figure 3A)
and epifluorescence images obtained from PFA-fixed coronal
slices (100 µm) 1 month later. Efficient transduction of
hippocampal neurons was detected with a wide (about 1.4 mm)
anteroposterior diffusion of the virus from the injection site
(Figure 3B). Furthermore, animals recovered quickly with no
sign of damage at the injection site and no gross behavioral
abnormalities, suggesting that the expression of the heterologous
protein was well tolerated.
To assess the impact of REST inhibitory modulation by
PAH1 on gene transcription, we employed the C450A (Salomon
et al., 2000) and I539E (Harper et al., 2004) light-independent
AsLOV2 variants tomimic the closed (inactive) and open (active)
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FIGURE 2 | (A) Confocal images of coronal cortico-hippocampal slices
derived from mice treated with either saline or kainic acid (KA; 25 mg/kg).
Slices were labeled with anti RE-1 Silencing Transcription factor (anti-REST),
anti-Neuronal Nuclei (anti-NeuN), and anti-GFAP antibodies, and with
Hoechst to visualize nuclei, as indicated. High-magnification images
corresponding to the boxed regions are shown for each staining. Scale bars:
300 µm in low-magnification images, 100 µm in high-magnification images.
(B) The cortico-hippocampal region from saline- (control) or KA-injected mice
was dissected at the indicated times after KA injection, lysed and processed
for western blotting using anti-REST antibodies (left). Anti-calnexin antibodies
were used to verify equal loading. Quantification of immunoreactive bands
showed increased REST immunoreactivity at 24 h. One-way ANOVA
(F(2,6) = 12.06; p = 0.0079) followed by Tukey’s multiple comparison test
(∗p < 0.05); n = 3. (C) Increasing doses of injected KA (5 mg/Kg) in
C57BL6/J mice induced seizures of increasing severity in a progressively
higher percentage of animals. At 25 mg/Kg all animals reproducibly
developed seizures.
state of the AsLOV2 protein, in which the inhibitory peptide
is hidden or exposed, respectively. One month after the AAV
injection, hippocampi of transduced mice were dissected and a
gene expression analysis was performed through the Nanostring
nCounter technology (Geiss et al., 2008), which allowed us
to quantitatively assess the expression of a panel of neuronal
FIGURE 3 | (A) Scheme of the in vivo experiment. C57Bl6/J male mice were
subjected to stereotaxic injection within the hippocampus with recombinant
AAV1/2 particles (0.65 µl-0.75 µl/hemisphere) expressing the constitutively
closed [AsLOV2(C450A)-PAH1] or constitutively open [AsLOV2(I539E)-PAH1]
probes, let recover for 4–5 weeks and sacrificed for gene expression studies.
(B) Brain coronal slices (100 µm thickness) were prepared from
paraformaldehyde (PFA)-fixed brain of AAV1/2-AsLOV2 injected mice (0.65
µl-0.75 µl/hemisphere), and transduced neurons in the hippocampus were
detected by epifluorescence microscopy. Acquired images of four
consecutive slices showed a high level of expression at the injection site, and
a wide antero/posterior spread of the virus. Image 2 was taken at the injection
site (from Bregma: AP 2.2, LAT 1.5; from brain: Z 1.65), the other images
were acquired from slices at 100 µm intervals. Scale bars: 200 µm in
low-magnification images, 100 µm in high-magnification images. (C) mRNA
expression from the hippocampus of animals expressing either the
constitutively open or the constitutively closed probe was analyzed using the
Nanostring nCounter technology. We analyzed n = 3 animals per experimental
group; a total of 64 REST-target (RE1-containing) genes were analyzed and
the values were normalized against five housekeeping genes and for GFP
expression. Results are color-coded separately within each gene: green color
for low expression, red color for high expression. The complete list of genes
and accession numbers is available in Supplementary Table S2; the
expression values are available in Supplementary Table S3. (D) The
expression of selected genes in the two experimental groups was validated
by real time (RT)-PCR. Mann-Whitney test; n.s., non statistically significant
(p > 0.05), ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001; n = 12. Bars represent
medians; whiskers represent interquartile ranges. The list of genes and
accession numbers for RT-PCR is available in Supplementary Table S1.
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REST-target and non target genes (Supplementary Table S2).
Interestingly, this analysis revealed a broad upregulation of
all genes analyzed in animals expressing the active probe,
compared to animals expressing the inactive probe (Figure 3C,
Supplementary Table S3). Of particular interest, we observed
the upregulation of synaptic genes (Gphn, L1cam, Nrx1, Shank,
Snap25, Syn 1, Syp and several Syt), genes associated with
inhibitory (Gabra1, Gabrg2, Glra3, Sst) and excitatory (Gria2,
Grin1, Grin2b) transmission, and potassium channels (Hcn1,
Hcn3, Kcnc2, Kcnh1, Kcnip2, Kcnq1). The changes in the
expression of a subset of these genes and of some related genes
were also analyzed through quantitative real-time PCR analysis,
confirming the Nanostring results (Figure 3D). Altogether,
these results suggest that mice expressing the open probe
are characterized by an increased expression of a cluster of
genes playing key roles in intrinsic excitability and synaptic
transmission resulting from an inhibitory influence on the
transcriptional repressor activity of REST.
Chronic REST Inhibition Reduces the
Susceptibility to KA-Induced Seizures
To address the impact of REST inhibition on epileptogenesis,
mice were injected with either the open or the closed probe
and after 1 month of recovery, they received a single challenge
dose of KA to induce seizures. After KA injection, mice were
video-monitored for 1 h to detect seizure onset and severity,
and quantified using a modified Racine scale (Figure 4A).
Remarkably, animals expressing the active probe were less prone
to the convulsant action of KA, showing a lower percentage of
animals with severe attacks (classified as severity 5 or 6) and
an overall reduced seizure score, compared to mice expressing
the inactive control probe (Figures 4B,C). Interestingly, the
analysis of the seizure latency suggests that animals with the
active probe experience behavioral signs of the seizure later than
mice expressing the inactive probe (Figure 4D). In particular, the
majority of control animals developed behavioral alterations in
the first 20 min, while the majority of mice with the open probe
did it in the last 40 min of observation.
DISCUSSION
In this work, we have assessed the impact of long-term, mild
inhibition of REST activity on the susceptibility to KA-induced
seizures. To do that, rather than directly interfering with the
REST-DNA binding, we adopted the strategy of preventing REST
activation by mSin3 binding to its N-terminal domain. We
previously described that a chimera of the minimal inhibitory
peptide PAH1 with the switchable AsLOV domain was able to
inhibit REST activity and de-repress the transcription of REST
target genes in primary neurons when AsLOV was in the open
state (unfolded Jα-helix) and the PAH1 peptide was accordingly
exposed (Paonessa et al., 2016). To make this photoswitchable
inhibition constitutively active, we generated a point mutant of
AsLOV (AsLOV2C450A) in which the Jα-helix is permanently
unfolded and used an alternative point mutant (AsLOV2I539E),
in which the Jα-helix is permanently folded as a negative control
(Paonessa et al., 2016).
As REST expression is increased in KA-induced seizures,
we asked whether this increase has a compensatory or rather
causal role in the epileptogenic activity triggered by KA. To
this aim, the AsLOV2-PAH1 tool, which had been previously
shown to work effectively in vitro (Paonessa et al., 2016),
has been for the first time employed in vivo. AsLOV2-PAH1
was efficiently expressed in the hippocampus upon intracranial
AAV injection and very well tolerated by the transduced mice,
which did not show any gross behavioral alteration upon probe
expression. The active probe was correctly working in vivo
since the hippocampi of transduced mice expressing the active
probe were characterized by moderate upregulation of all
the REST-target genes, as expected by the chronic effective
inhibition of REST repressor activity. Of note, we observed the
upregulation of both REST-target and non-target genes, likely
reflecting a cascade of effects whereby the initial de-repression
of REST-target genes leads to a wider upregulation of neuronal
genes. Among up-regulated genes there were clusters playing key
roles in intrinsic excitability and synaptic transmission. Genes
bi-directionally controlling intrinsic excitability included sodium
(Scn2a1, Scn3a, Scn3b, Scn8a, Hcn1, Hcn3), calcium (Cacna1h,
Cacna1i, Cacng2) and potassium (Kcnc2, Kcnh1, Kcnip2, Kcnq1)
channels. Moreover, a large array of genes playing key roles
in both inhibitory and excitatory synaptic transmission were
activated, including (i) presynaptic actors of synaptic vesicle
trafficking and exocytosis (Syn1, Syp, Syt2, Syt4, Syt7, Scg2, Sst);
(ii) glutamate (Gria2, Grin1, Grin2, Shank2) and GABA/glycine
(Gabra1, Gabrg2, Gphn, Glra3) receptor complexes; (iii) synaptic
adhesion molecules (L1cam, Nrxn1, Nfasc); (iv) immediate early
genes (fos, arc); (v) protein kinases involved in transcriptional
control and homeostatic plasticity (Camk4; Map2k2, Map3k5,
Prkcb1); (vi) neurotrophin signaling (Bdnf, Ntrk3); and (vii)
calcium-binding molecules (Calb1, Hpca).
When mice expressing the open and close constructs were
challenged with a single KA injection, animals expressing the
active probe showed decrease propensity to develop seizures,
which were also less severe. In fact, a lower percentage of animals
expressing the active probe experienced tonic-clonic attacks,
while the vast majority of them showed a mild phenotype,
mainly characterized by tail extension and/or forepaws shaking.
In addition, control mice displayed behavioral signs of seizure
in a much shorter time, again indicating that mice transduced
with the active probe were more resistant to the convulsive
insult. Since the inhibition of REST activity was constitutive,
the administration of the convulsant to trigger seizures found
mice in a ‘‘low-REST’’/‘‘enhanced neuronal phenotype’’ state,
i.e., with upregulation of many gene clusters. Such a global
change in the transcriptional profile of neuron-specific genes
controlling neuronal communication and network activity, as
revealed by our gene expression analysis, is compatible with
tighter control of intrinsic excitability and strengthening of both
excitatory and inhibitory synaptic connections. This can render
neuronal network less susceptible to external stimuli trying
to shift the excitation/inhibition balance, by potentiating the
push-pull control on depolarizing-hyperpolarizing conductances
and on the balance between excitatory and inhibitory synaptic
transmission and short-term plasticity. Moreover, the observed
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FIGURE 4 | (A) Scheme of the in vivo experiment. C57Bl6/J mice (12–24 weeks old) were subjected to stereotaxic injection within the hippocampus of recombinant
AAV1/2 particles (0.65 µl-0.75 µl/hemisphere) expressing either the constitutively closed [AsLOV2(C450A)-PAH1] or the constitutively open [AsLOV2(I539E)-PAH1]
probes, let recover for 4–5 weeks and subsequently injected with kainate (KA, 25 mg/Kg) to induce seizures. Mice were continuously video-monitored for 1 h after
KA injection to track and score seizures. Seizure severity was graded as described in the “Materials and Methods” section. (B) When compared to mice injected with
the inactive variant, a low percentage of mice injected with the active variant showed severe seizure attacks (score 5/6). (C) Bar graphs indicate the percentage of
animals for each severity score. Mice expressing the active probe displayed a mild phenotype when compared to control animals. (D) Single points represent the
individual latency to the highest severity score. The majority of mice expressing the active probe experienced behavioral signs of seizures later than the animals
expressing the inactive probe. n = 11 mice expressing the closed probe; n = 10 mice expressing the open probe. ∗p < 0.05; Chi-squared test.
upregulation of K+ channels and of GABA/glycine receptors
may represent a brake towards hyperexcitability, making neurons
more refractory to the actions of convulsant drugs such as
KA. Alterations of REST expression and/or activity have been
associated with the onset of epilepsy, although the precise
role of this factor in the progression of the pathology is
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still debated, and likely depends on the model employed
and on the cell type analyzed (Hu et al., 2011; Liu et al.,
2012; Patterson et al., 2017). Our findings are consistent
with previous studies, which implicated REST in maintaining
neuronal homeostasis and reducing the hyperexcitation of the
network (Pozzi et al., 2013; Pecoraro-Bisogni et al., 2018;
Zullo et al., 2019).
Our results support the notion that REST is actively
contributing to the epileptic phenotype, as the chronic inhibition
of its activity makes animals less prone to develop seizures
upon KA challenge. Future studies will address with more
specificity the cell type(s) where REST action is more prominent,
by selectively expressing the probe in specific neural cell
populations. Moreover, it will be crucial to identify more
precisely the time window of REST inhibition that is sufficient
to inhibit seizure development, so that appropriate strategies
could be designed to exploit REST as molecular target for
the treatment of paroxysmal neuropathologies characterized by
network hyperexcitability.
DATA AVAILABILITY STATEMENT
All datasets generated for this study are included in the
article/Supplementary Material.
ETHICS STATEMENT
The animal study was reviewed and approved by the Italian
Ministry of Health (Authorization # 73-2014-PR onDec 5, 2014),
and was carried out in accordance with the guidelines established
by the European Community Council (Directive 2010/63/EU of
22 September 2010).
AUTHOR CONTRIBUTIONS
EC performed molecular cloning, AAV production, cell
and primary neuron infection, biochemistry and confocal
imaging, and RT-PCR analysis. FBu performed REST
immunohistochemistry and immunoblotting on wild type
animals. AR performed immunoblotting, supervised cell
and molecular biology and biochemistry experiments. CM
performed the in vivo experiments and seizure scoring. FC
performed Nanostring analysis and wrote the article. FBe
supervised the project and wrote the article.
FUNDING
This study was supported by research grants from the
European Commission and CURE Epilepsy (FP7 Integrating
Project ‘‘DESIRE,’’ grant number 602531 and CURE Innovation
Award to FBe, and by the Italian Ministry of Health Ricerca
Finalizzata (GR-2013-02355540 to AR).
ACKNOWLEDGMENTS
Dr. M. Cilli is gratefully acknowledged for his help with
in vivo experiments. A. Mehilli is acknowledged for primary cell
culture preparations, D. Moruzzo, R. Ciancio and I. Dallorto for
technical and administrative support.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fncel.
2019.00580/full#supplementary-material.
REFERENCES
Andrés, M. E., Burger, C., Peral-Rubio, M. J., Battaglioli, E., Anderson, M. E.,
Grimes, J., et al. (1999). CoREST: a functional corepressor required for
regulation of neural-specific gene expression. Proc. Natl. Acad. Sci. U S A 96,
9873–9878. doi: 10.1073/pnas.96.17.9873
Ariano, P., Zamburlin, P., D’Alessandro, R., Meldolesi, J., and Lovisolo, D. (2010).
Differential repression by the transcription factor REST/NRSF of the various
Ca2+ signalling mechanisms in pheochromocytoma PC12 cells. Cell Calcium
47, 360–368. doi: 10.1016/j.ceca.2010.01.007
Baldelli, P., and Meldolesi, J. (2015). The transcription repressor REST in
adult neurons: physiology, pathology, and diseases. eNeuro 2:ENEURO.0010-
15.2015. doi: 10.1523/eneuro.0010-15.2015
Ballas, N., Battaglioli, E., Atouf, F., Andres, M. E., Chenoweth, J., Anderson, M. E.,
et al. (2001). Regulation of neuronal traits by a novel transcriptional complex.
Neuron 31, 353–365. doi: 10.1016/s0896-6273(01)00371-3
Ballas, N., Grunseich, C., Lu, D. D., Speh, J. C., and Mandel, G. (2005). REST
and its corepressors mediate plasticity of neuronal gene chromatin throughout
neurogenesis. Cell 121, 645–657. doi: 10.1016/j.cell.2005.03.013
Bruce, A. W., Donaldson, I. J., Wood, I. C., Yerbury, S. A., Sadowski, M. I.,
Chapman, M., et al. (2004). Genome-wide analysis of repressor element
1 silencing transcription factor/neuron-restrictive silencing factor
(REST/NRSF) target genes. Proc. Natl. Acad. Sci. U S A 101, 10458–10463.
doi: 10.1073/pnas.0401827101
Calderone, A., Jover, T., Noh, K. M., Tanaka, H., Yokota, H., Lin, Y., et al. (2003).
Ischemic insults derepress the gene silencer REST in neurons destined to die.
J. Neurosci. 23, 2112–2121. doi: 10.1523/JNEUROSCI.23-06-02112.2003
Cheong, A., Bingham, A. J., Li, J., Kumar, B., Sukumar, P., Munsch, C., et al.
(2005). Downregulated REST transcription factor is a switch enabling critical
potassium channel expression and cell proliferation. Mol. Cell 20, 45–52.
doi: 10.1016/j.molcel.2005.08.030
Chong, J. A., Tapia-Ramírez, J., Kim, S., Toledo-Aral, J. J., Zheng, Y.,
Boutros, M. C., et al. (1995). REST: a mammalian silencer protein that
restricts sodium channel gene expression to neurons. Cell 80, 949–957.
doi: 10.1016/0092-8674(95)90298-8
D’Alessandro, R., Klajn, A., and Meldolesi, J. (2009). Expression of dense-core
vesicles and of their exocytosis are governed by the repressive transcription
factor NRSF/REST. Ann. N Y Acad. Sci. 1152, 194–200. doi: 10.1111/j.1749-
6632.2008.03988.x
Formisano, L., Noh, K. M., Miyawaki, T., Mashiko, T., Bennett, M. V., and
Zukin, R. S. (2007). Ischemic insults promote epigenetic reprogramming of mu
opioid receptor expression in hippocampal neurons. Proc. Natl. Acad. Sci. U S A
104, 4170–4175. doi: 10.1073/pnas.0611704104
Garriga-Canut, M., Schoenike, B., Qazi, R., Bergendahl, K., Daley, T. J.,
Pfender, R. M., et al. (2006). 2-Deoxy-D-glucose reduces epilepsy progression
by NRSF-CtBP-dependent metabolic regulation of chromatin structure. Nat.
Neurosci. 9, 1382–1387. doi: 10.1038/nn1791
Geiss, G. K., Bumgarner, R. E., Birditt, B., Dahl, T., Dowidar, N., Dunaway, D. L.,
et al. (2008). Direct multiplexed measurement of gene expression with color-
coded probe pairs. Nat. Biotechnol. 26, 317–325. doi: 10.1038/nbt1385
Grimes, J. A., Nielsen, S. J., Battaglioli, E., Miska, E. A., Speh, J. C.,
Berry, D. L., et al. (2000). The co-repressor mSin3A is a functional component
of the REST-CoREST repressor complex. J. Biol. Chem. 275, 9461–9467.
doi: 10.1074/jbc.275.13.9461
Frontiers in Cellular Neuroscience | www.frontiersin.org 9 January 2020 | Volume 13 | Article 580
Carminati et al. REST Inhibition Reduces Seizure Susceptibility
Harper, S. M., Christie, J. M., and Gardner, K. H. (2004). Disruption of the
LOV-Jα helix interaction activates phototropin kinase activity. Biochemistry 43,
16184–16192. doi: 10.1021/bi048092i
Hu, X. L., Cheng, X., Cai, L., Tan, G. H., Xu, L., Feng, X. Y., et al.
(2011). Conditional deletion of NRSF in forebrain neurons accelerates
epileptogenesis in the kindling model. Cereb. Cortex 21, 2158–2165.
doi: 10.1093/cercor/bhq284
Johnson, D. S., Mortazavi, A., Myers, R. M., and Wold, B. (2007). Genome-
wide mapping of in vivo protein-DNA interactions. Science 316, 1497–1502.
doi: 10.1126/science.1141319
Jothi, R., Cuddapah, S., Barski, A., Cui, K., and Zhao, K. (2008). Genome-wide
identification of in vivo protein-DNAbinding sites fromChIP-Seq data.Nucleic
Acids Res. 36, 5221–5231. doi: 10.1093/nar/gkn488
Liu, M., Sheng, Z., Cai, L., Zhao, K., Tian, Y., and Fei, J. (2012). Neuronal
conditional knockout of NRSF decreases vulnerability to seizures induced
by pentylenetetrazol in mice. Acta Biochim. Biophys. Sin. 44, 476–482.
doi: 10.1093/abbs/gms023
Lu, T., Aron, L., Zullo, J., Pan, Y., Kim, H., Chen, Y., et al. (2014). REST and
stress resistance in ageing and Alzheimer’s disease. Nature 507, 448–454.
doi: 10.1038/nature13163
McClelland, S., Brennan, G. P., Dubé, C., Rajpara, S., Iyer, S., Richichi, C.,
et al. (2014). The transcription factor NRSF contributes to epileptogenesis by
selective repression of a subset of target genes. Elife 3:e01267. doi: 10.7554/elife.
01267
McClelland, S., Flynn, C., Dubé, C., Richichi, C., Zha, Q., Ghestem, A., et al. (2011).
Neuron-restrictive silencer factor-mediated hyperpolarization-activated cyclic
nucleotide gated channelopathy in experimental temporal lobe epilepsy. Ann.
Neurol. 70, 454–464. doi: 10.1002/ana.22479
McClure, C., Cole, K. L., Wulff, P., Klugmann, M., and Murray, A. J. (2011).
Production and titering of recombinant adeno-associated viral vectors. J. Vis.
Exp. 57:e3348. doi: 10.3791/3348
McLeod, F., Ganley, R., Williams, L., Selfridge, J., Bird, A., and Cobb, S. R.
(2013). Reduced seizure threshold and altered network oscillatory properties
in a mouse model of Rett syndrome. Neuroscience 231, 195–205. doi: 10.1016/j.
neuroscience.2012.11.058
Mortazavi, A., Leeper Thompson, E. C., Garcia, S. T., Myers, R. M., and Wold, B.
(2006). Comparative genomicsmodeling of theNRSF/REST repressor network:
from single conserved sites to genome-wide repertoire. Genome Res. 16,
1208–1221. doi: 10.1101/gr.4997306
Negrini, S., Prada, I., D’Alessandro, R., and Meldolesi, J. (2013). REST: an
oncogene or a tumor suppressor? Trends Cell Biol. 23, 289–295. doi: 10.1016/j.
tcb.2013.01.006
Otto, S. J., McCorkle, S. R., Hover, J., Conaco, C., Han, J. J., Impey, S., et al.
(2007). A new binding motif for the transcriptional repressor REST uncovers
large gene networks devoted to neuronal functions. J. Neurosci. 27, 6729–6739.
doi: 10.1523/JNEUROSCI.0091-07.2007
Palm, K., Belluardo, N., Metsis, M., and Timmusk, T. (1998). Neuronal expression
of zinc finger transcription factor REST/NRSF/XBR gene. J. Neurosci. 18,
1280–1296. doi: 10.1523/JNEUROSCI.18-04-01280.1998
Paonessa, F., Criscuolo, S., Sacchetti, S., Amoroso, D., Scarongella, H., Pecoraro
Bisogni, F., et al. (2016). Regulation of neural gene transcription by optogenetic
inhibition of the RE1-silencing transcription factor. Proc. Natl. Acad. Sci. U S A
113, E91–E100. doi: 10.1073/pnas.1507355112
Paonessa, F., Latifi, S., Scarongella, H., Cesca, F., and Benfenati, F. (2013).
Specificity protein 1 (Sp1)-dependent activation of the synapsin I gene
(SYN1) is modulated by RE1-silencing transcription factor (REST) and 5’-
cytosine-phosphoguanine (CpG) methylation. J. Biol. Chem. 288, 3227–3239.
doi: 10.1074/jbc.m112.399782
Patterson, K. P., Barry, J. M., Curran, M. M., Singh-Taylor, A., Brennan, G.,
Rismanchi, N., et al. (2017). Enduring memory impairments provoked by
developmental febrile seizures are mediated by functional and structural
effects of neuronal restrictive silencing factor. J. Neurosci. 37, 3799–3812.
doi: 10.1523/JNEUROSCI.3748-16.2017
Pecoraro-Bisogni, F., Lignani, G., Contestabile, A., Castroflorio, E., Pozzi, D.,
Rocchi, A., et al. (2018). REST-dependent presynaptic homeostasis
induced by chronic neuronal hyperactivity. Mol. Neurobiol. 55, 4959–4972.
doi: 10.1007/s12035-017-0698-9
Pozzi, D., Lignani, G., Ferrea, E., Contestabile, A., Paonessa, F., D’Alessandro, R.,
et al. (2013). REST/NRSF-mediated intrinsic homeostasis protects neuronal
networks from hyperexcitability. EMBO J. 32, 2994–3007. doi: 10.1038/emboj.
2013.231
Qiang, M., Rani, C. S., and Ticku, M. K. (2005). Neuron-restrictive silencer factor
regulates the N-methyl-D-aspartate receptor 2B subunit gene in basal and
ethanol-induced gene expression in fetal cortical neurons.Mol. Pharmacol. 67,
2115–2125. doi: 10.1124/mol.104.010751
Racine, R. J. (1972). Modification of seizure activity by electrical stimulation.
II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32, 281–294.
doi: 10.1016/0013-4694(72)90177-0
Rodenas-Ruano, A., Chávez, A. E., Cossio, M. J., Castillo, P. E., and
Zukin, R. S. (2012). REST-dependent epigenetic remodeling promotes the
developmental switch in synaptic NMDA receptors. Nat. Neurosci. 15,
1382–1390. doi: 10.1038/nn.3214
Salomon, M., Christie, J. M., Knieb, E., Lempert, U., and Briggs, W. R.
(2000). Photochemical and mutational analysis of the FMN-binding domains
of the plant blue light receptor, phototropin. Biochemistry 39, 9401–9410.
doi: 10.1021/bi000585+
Schoenherr, C. J., and Anderson, D. J. (1995). The neuron-restrictive silencer
factor (NRSF): a coordinate repressor ofmultiple neuron-specific genes. Science
267, 1360–1363. doi: 10.1126/science.7871435
Spencer, E. M., Chandler, K. E., Haddley, K., Howard, M. R., Hughes, D.,
Belyaev, N. D., et al. (2006). Regulation and role of REST and
REST4 variants in modulation of gene expression in in vivo and in vitro
in epilepsy models. Neurobiol. Dis. 24, 41–52. doi: 10.1016/j.nbd.2006.
04.020
Timmusk, T., Palm, K., Lendahl, U., and Metsis, M. (1999). Brain-derived
neurotrophic factor expression in vivo is under the control of neuron-restrictive
silencer element. J. Biol. Chem. 274, 1078–1084.
van Loo, K. M., Schaub, C., Pernhorst, K., Yaari, Y., Beck, H., Schoch, S.,
et al. (2012). Transcriptional regulation of T-type calcium channel CaV3.2:
bi-directionality by early growth response 1 (Egr1) and repressor element
1 (RE-1) protein-silencing transcription factor (REST). J. Biol. Chem. 287,
15489–15501. doi: 10.1074/jbc.m111.310763
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A.,
et al. (2002). Accurate normalization of real-time quantitative RT-PCR data
by geometric averaging of multiple internal control genes. Genome Biol.
3:RESEARCH0034. doi: 10.1186/gb-2002-3-7-research0034
Yeo, M., Berglund, K., Augustine, G., and Liedtke, W. (2009). Novel repression of
Kcc2 transcription by REST-RE-1 controls developmental switch in neuronal
chloride. J. Neurosci. 29, 14652–14662. doi: 10.1523/JNEUROSCI.2934-
09.2009
Zuccato, C., Belyaev, N., Conforti, P., Ooi, L., Tartari, M., Papadimou, E., et al.
(2007). Widespread disruption of repressor element-1 silencing transcription
factor/neuron-restrictive silencer factor occupancy at its target genes in
Huntington’s disease. J. Neurosci. 27, 6972–6983. doi: 10.1523/JNEUROSCI.
4278-06.2007
Zuccato, C., Tartari, M., Crotti, A., Goffredo, D., Valenza, M., Conti, L., et al.
(2003). Huntingtin interacts with REST/NRSF to modulate the transcription
of NRSE-controlled neuronal genes. Nat. Genet. 35, 76–83. doi: 10.1038/
ng1219
Zullo, J. M., Drake, D., Aron, L., O’Hern, P., Dhamne, S. C., Davidsohn, N.,
et al. (2019). Regulation of lifespan by neural excitation and REST. Nature 574,
359–364. doi: 10.1038/s41586-019-1647-8
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2020 Carminati, Buffolo, Rocchi, Michetti, Cesca and Benfenati. This
is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) and the copyright owner(s) are credited
and that the original publication in this journal is cited, in accordance with accepted
academic practice. No use, distribution or reproduction is permitted which does not
comply with these terms.
Frontiers in Cellular Neuroscience | www.frontiersin.org 10 January 2020 | Volume 13 | Article 580
